Previous studies indicated that there is a separate hypothalamic control of follicle-stimulating hormone (FSH) release distinct from that of luteinizing hormone (LH). An FSH-releasing factor (FSHRF) was purified from rat and sheep hypothalami, but has not been isolated. We hypothesized that FSHRF might be an analogue of mammalian luteinizing hormone-releasing hormone (m-LHRH) and evaluated the ...

Plasma concentrations of luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin (PRL) were determined over a 24-h period using radioimmunoassay in sheep injected with corn oil (control) or various doses of zeranol or estradiol-17 beta. Injection of .333, 1 or 10 mg of zeranol caused dose-related increases (P less than .01) in plasma PRL (peak levels at 12 to 18 h) and LH (pe...

Polycystic Ovary Syndrome (PCOS) is a widespread endocrine-reproductive-metabolic condition with severe implications for females’ health. The role of four essential parameters on PCOS, including Human Leukocyte Antigens (HLA) represented by the HLA-B*0702 allele, anti-Follicle Stimulating Hormone (anti-FSH) antibodies, anti-Luteinizing (anti-LH) and vitamin D3 was investigated. A total 100 samp...

The secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH) is partly regulated by a non-steroid factor, inhibin, present in the testicular lymph and rete testis fluid (RTF). We were interested to know whether the RTF excreted into the epididymis has a regulatory role on the secretion of FSH and LH. The remaining rete testis of 6 adult rams hemicastrated 6 to 10 months earl...

OBJECTIVE To evaluate the effect of low levels of endogenous luteinizing hormone (LH) and low-dose human chorionic gonadotropin (hCG) supplementation on in vitro fertilization (IVF) cycle outcomes in a gonadotropin-releasing hormone (GnRH) antagonist protocol. DESIGN Retrospective study. SETTING Military medical center. PATIENT(S) General in vitro fertilization/embryo transfer (IVF-ET) po...

In this immunocytochemical study, heterogeneity in the storage of gonadotropins in the sheep fetus was investigated. LH cells were first detected at 50 days of gestation, whereas FSH and LH-FSH cells were observed from Day 89 on; no gonadotropes containing ACTH were observed. LH cell percentage increased for both sexes between 99 and 120 days of gestation (from 2.8 +/- 0.1 to 4.0 +/- 0.3), rema...

Ovarian cancer is the most lethal gynecological malignancy affecting American women. The gonadotropins, follicle stimulating hormone (FSH) and luteinizing hormone (LH), have been implicated as growth factors in ovarian cancer. In the present study, pathways activated by FSH and LH in normal ovarian surface epithelium (OSE) grown in their microenvironment were investigated. Gonadotropins increas...

Abstract Polycystic Ovarian Syndrome (PCOS) is a disease that characterized by an increased Gonadotropin-Releasing-Hormone (GnRH) pulsatile frequency, causing altered LH/FSH ratio. More precisely Luteinizing Hormone (LH) secretion compared to decreased Follicle-Stimulating (FSH) leads the development of hyperandrogenism and low-level concentration estrogens therefore negative estrogenic feedbac...